Predictive Effects of Platelet Indices in Cirrhotic Patients with or without Portal Vein Thrombosis

Filiz Araz; Barış Soydaş

doi:10.58600/eurjther1832

Authors

Filiz Araz Department of Gastroenterology, Faculty of Medicine, Baskent University Adana Dr. Turgut Noyan Training and Research Hospital, Adana, Turkey https://orcid.org/0000-0003-0780-5680
Barış Soydaş Department of Gastroenterology, Faculty of Medicine, Baskent University Adana Dr. Turgut Noyan Training and Research Hospital, Adana, Turkey https://orcid.org/0000-0002-9558-690X

DOI:

https://doi.org/10.58600/eurjther1832

Keywords:

cirrhosis, Platelet indices, portal vein thrombosis.

Abstract

Objective: Portal vein thrombosis (PVT) is a common finding in liver cirrhosis. Besides low portal blood flow, thrombophilia, bacterial translocation and endotoxemia, platelets which are considered as important source of prothrombotic agents may play a role in thrombotic events in cirrhosis. Large platelets have been reported to have numerous granules that result in greater thrombotic and proinflammatory activity. We aimed to define the role of platelet indices in PVT among cirrhotic patients.

Method: Cirrhotic patients admitted to Gastroenterology Clinic and having a dynamic radiological examination were assessed retrospectively. Demographic and laboratory findings were recorded including platelet distribution width (PDW) and mean platelet volume (MPV). Severity of cirrhosis was assessed with MELD (Model for End Stage Liver Disease) and Child-Pugh-Turcotte (CPT) scores

Results: Study included 255 patients. Mean age was 60.6±10.2 years. 41.6% of patients were female. 50 (19.6%) patients had PVT. Patients with PVT did not differed from those without PVT in age, gender and presence of diabetes mellitus. Median platelet count was lower in patients with PVT (100 (22-370) vs 79,5 (22-573), p: 0,033). Mean MPV and PDW levels were similar between PVT and non-PVT groups (p >0.05). Although median MELD scores did not differ between groups, median CPT scores were significantly higher in PVT compared to non-PVT group (p:0,027).

Conclusion: Cirrhotic patients with PVT had more prominent thrombocytopenia, but similar MPV and PDW levels compared to those without PVT.

Metrics

Metrics Loading ...

References

Intagliata NM, Caldwell SH, Armando Tripodi A (2019) Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients with and without Cirrhosis. Gastroenterology 156:1582-1599. https://doi.org/10.1053/j.gastro.2019.01.265

Pan J, Wang L, Gao F, An Y, Yin Y, Guo X, Nery FG, Yoshida EM, Qi X (2022) Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. Eur J Intern Med 104:21-32. https://doi.org/10.1016/j.ejim.2022.05.032

Ferreira CN, Marinho RT, Cortez-Pinto H, Ferreira P, Dias MS, Vasconcelos M, Alexandrino P, Serejo HF, Pedro AJ, Goncalves A, Palma S, Leite I, Reis D, Damiao F, Valente A, Brita LX, Baldaia C, Fatela N, Ramalho F, Velosa J (2019) Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study. Liver Int 39(8):1459-67. https://doi.org/10.1111/liv.14121

Nery F, Chevret S, Condat B, de Raucourt E, Boudaoud L, Rautou P-E, Plessier A, Roulot D, Chaffaut C, Bourcier V, Trinchet J-C, Valla D-C (2015) Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology 61(2):660-7. https://doi.org/10.1002/hep.27546

Harding DJ, Perera, Chen F, Olliff S, Tripathi D (2015). Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol 14,21(22):6769-84. https://dx.doi.org/10.3748/wjg.v21.i22.6769

Abdel-Razik A, Eldars W, Rizk E (2014) Platelet indices and inflammatory markers as diagnostic predictors for ascitic fluid infection. Eur J Gastroenterol Hepatol 26:1342-1347. https://doi.org/10.1097/MEG.0000000000000202

Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7(2):157-161. https://doi.org/10.1097/00001721-199603000-00011

Colkesen Y, Muderrisoglu H (2012) The role of mean platelet volume in predicting thrombotic events. Clin Chem Lab 50(4):631-634. https://doi.org/10.1515/cclm.2011.806

Kannan M, Ahmad F, Saxena R (2019) Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings. Blood Reviews 37;100583. https://doi.org/10.1016/j.blre.2019.05.007

Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Stormer J, Hansen JB (2010). Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø study. Journal of Thrombosis and Haemostasis. 8(1):157-162. https://doi.org/10.1111/j.1538-7836.2009.03498.x

Abdel-Razik A, Mousa N, Elhelaly R, Tawfik A (2015) De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system. Eur J Gastroenterol Hepatol 27(5):585-92. https://doi.org/10.1097/MEG.0000000000000325.

Greisenegger S, Endler G, Hsieh K, Tentschert S, Mannhalter C, Lalouschek W (2004) Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke. 35 (7): 1688-1691. https://doi.org/10.1161/01.STR.0000130512.81212.a2

Chang HA, Hwang HS, Park HK, Chun MY, Sung JY (2010) The Role of Mean Platelet Volume as a Predicting Factor of Asymptomatic Coronary Artery Disease. Korean J Fam Med. 31;600-606. https://doi.org/10.4082/kjfm.2010.31.8.600

Klovaite J, Benn M, Yazdanyar S, Nordestgaard B.G (2011) High platelet volume and increased risk of myocardial infarction: 39 531 participants from the general population. J Thromb Haemost. 9;49-56. https://doi.org/10.1111/j.1538-7836.2010.04110.x

Sansanayudh N, Anothaisintawee T, Muntham D, McEvoy M, Attia J, Thakkinstian A (2014) Mean platelet volume and coronary artery disease: a systematic review and meta-analysis Int J Cardiol 20;175(3):433-40. https://doi.org/10.1016/j.ijcard.2014.06.028

Lin W, Wu Y, Lu X, Hu Y (2021) Association between mean platelet volume and pulmonary embolism: a systematic review and meta-analysis. Aging (Albany NY) 13(13):17253-17273. https://doi.org/10.18632/aging.203205

Gîrleanu I, Trifan A, Stanciu C, Sfarti C (2018). Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big Picture. World J Gastroenterol. 24(39):4419-4427. https://doi.org/10.3748/wjg.v24.i39.4419

Fimognari FL, Violi F (2008) Portal vein thrombosis in liver cirrhosis. Intern Emerg Med. 3:213-218. https://doi.org/10.1007/s11739-008-0128-0

Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, Pompili M, Rapaccini GL, Tondi P, Gasbarrini GB, Landolfi R, Gasbarrini A (2009). Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 51:682-689. https://doi.org/10.1016/j.jhep.2009.03.013

Senzolo M, Garcia-Tsao G, García-Pagán JC (2021) Current knowledge and management of portal vein thrombosis in cirrhosis. J Hepatol. 75(2):442-453. https://doi.org/10.1016/j.jhep.2021.04.029

Mori H, Hayashi K, Uetani M, Matsuoka Y, Iwao M, Maeda H (1987) High-attenuation recent thrombus of the portal vein: CT demonstration and clinical significance. Radiology 163:353-356. https://doi.org/10.1148/radiology.163.2.3031725

Chen H, Trilok G, Wang F, Qi X, Xiao J, Yang C (2014) A single hospital study on portal vein thrombosis in cirrhotic patients – clinical characteristics & risk factors. Indian J Med Res 139:260-266.

Gîrleanu I, Trifan A, Cojocariu C, Sîngeap AM, Sfarti C, Stanciu C (2012) The risk of thrombotic events in patients with liver cirrhosis. Rev Med Chir Soc Med Nat Iasi 116:991-996. https://doi.org/10.3390/diagnostics13061160

Ushitora Y, Tashiro H, Takahashi S, Amano H, Oshita A, Kobayashi T, Chayama K, Ohdan H (2011) Splenectomy in chronic hepatic disorders: portal vein thrombosis and improvement of liver function. Dig Surg 28:9-14. https://doi.org/10.1159/000321886.

Afdhal N, McHutchison J, Brown R, Jacobson I, Manns M, Poordad F, Weksler B, Esteban R (2008) Thrombocytopenia associated with chronic liver disease. J Hepatol 48:1000-1007. https://doi.org/10.1016/j.jhep.2008.03.009

Gîrleanu I, Trifan A, Cojocariu C, Dimache M, Sîngeap AM, Stoica O, Sfarti C, Stanciu C (2013) Platelet indices in patients with de novo portal vein thrombosis and liver cirrhosis. Rev Med Chir Soc Med Nat Iasi 117(3):641-7. https://doi.org/10.1016/s0168-8278(14)60694-2

Sharma S, Kumar N, Bihana I, Uppal V, Ahluwalia J, Naseem S, Varma N, Rana SS (2021) Evaluation of platelet indices in patients with splanchnic vein thrombosis. Indian J Hematol Blood Transfus. 37(4):593-599. https://doi.org/10.1007/s12288-021-01400-5

Bath PM. The routine measurement of platelet size using sodium citrate alone as the anticoagulant. Thromb Haemost, 1993,70(4):687-690

Lin W, Lu X, Fan FJ, Hu Y (2018) Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies. Current Medical Science. 38(4):575-581. https://doi.org/10.1007/s11596-018-1916-z

Arap JP, Martin-Mateos RM, Shah VT (2018) Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg. Hepatology Int. 12,24-33. https://doi.org/10.1007/s12072-017-9798-x

Guo L, Rondia MT (2019) The Era of Thromboinflammation: Platelets Are Dynamic Sensors and Effector Cells During Infectious Diseases. Front Immunol 13:10:2204. https://doi.org/10.3389/fimmu.2019.02204

Xing Y, Tian Z, Jiang Y, Guan G, Niu Q, Sun X, Han R, Jing X (2022) A practical nomogram based on systemic inflammatory markers for predicting portal vein thrombosis in patients with liver cirrhosis. Ann Med. 54(1):302-309. https://doi.org/10.1080/07853890.2022.2028893

Nery F, Carneiro P, Correia S, Macedo C, Gandara J, Lopes V, Valadares D, Ferreira S, Oliveira J, Gomes MT, Miranda HP, Rautau P-E, Valla D (2021) Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study. Eur J Gastroenterol Hepatol. 1;33(1):e108-e113. https://doi.org/10.1097/MEG.0000000000001982